Literature DB >> 31567112

Fused Sparse Network Learning for Longitudinal Analysis of Mild Cognitive Impairment.

Peng Yang, Feng Zhou, Dong Ni, Yanwu Xu, Siping Chen, Tianfu Wang, Baiying Lei.   

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease with an irreversible and progressive process. To understand the brain functions and identify the biomarkers of AD and early stages of the disease [also known as, mild cognitive impairment (MCI)], it is crucial to build the brain functional connectivity network (BFCN) using resting-state functional magnetic resonance imaging (rs-fMRI). Existing methods have been mainly developed using only a single time-point rs-fMRI data for classification. In fact, multiple time-point data is more effective than a single time-point data in diagnosing brain diseases by monitoring the disease progression patterns using longitudinal analysis. In this article, we utilize multiple rs-fMRI time-point to identify early MCI (EMCI) and late MCI (LMCI), by integrating the fused sparse network (FSN) model with parameter-free centralized (PFC) learning. Specifically, we first construct the FSN framework by building multiple time-point BFCNs. The multitask learning via PFC is then leveraged for longitudinal analysis of EMCI and LMCI. Accordingly, we can jointly learn the multiple time-point features constructed from the BFCN model. The proposed PFC method can automatically balance the contributions of different time-point information via learned specific and common features. Finally, the selected multiple time-point features are fused by a similarity network fusion (SNF) method. Our proposed method is evaluated on the public AD neuroimaging initiative phase-2 (ADNI-2) database. The experimental results demonstrate that our method can achieve quite promising performance and outperform the state-of-the-art methods.

Entities:  

Mesh:

Year:  2020        PMID: 31567112     DOI: 10.1109/TCYB.2019.2940526

Source DB:  PubMed          Journal:  IEEE Trans Cybern        ISSN: 2168-2267            Impact factor:   11.448


  7 in total

1.  Diagnosis of Amnesic Mild Cognitive Impairment Using MGS-WBC and VGBN-LM Algorithms.

Authors:  Chunting Cai; Jiangsheng Cao; Chenhui Yang; E Chen
Journal:  Front Aging Neurosci       Date:  2022-05-30       Impact factor: 5.702

2.  Classification of early-MCI patients from healthy controls using evolutionary optimization of graph measures of resting-state fMRI, for the Alzheimer's disease neuroimaging initiative.

Authors:  Jafar Zamani; Ali Sadr; Amir-Homayoun Javadi
Journal:  PLoS One       Date:  2022-06-21       Impact factor: 3.752

3.  Attention-Guided Hybrid Network for Dementia Diagnosis With Structural MR Images.

Authors:  Chunfeng Lian; Mingxia Liu; Yongsheng Pan; Dinggang Shen
Journal:  IEEE Trans Cybern       Date:  2022-04-05       Impact factor: 11.448

4.  A Hybrid Deep Learning Method for Early and Late Mild Cognitive Impairment Diagnosis With Incomplete Multimodal Data.

Authors:  Leiming Jin; Kun Zhao; Yan Zhao; Tongtong Che; Shuyu Li
Journal:  Front Neuroinform       Date:  2022-03-15       Impact factor: 4.081

5.  Convolutional Neural Networks for Classification of T2DM Cognitive Impairment Based on Whole Brain Structural Features.

Authors:  Xin Tan; Jinjian Wu; Xiaomeng Ma; Shangyu Kang; Xiaomei Yue; Yawen Rao; Yifan Li; Haoming Huang; Yuna Chen; Wenjiao Lyu; Chunhong Qin; Mingrui Li; Yue Feng; Yi Liang; Shijun Qiu
Journal:  Front Neurosci       Date:  2022-07-19       Impact factor: 5.152

6.  Brain disorder prediction with dynamic multivariate spatio-temporal features: Application to Alzheimer's disease and autism spectrum disorder.

Authors:  Jianping Qiao; Rong Wang; Hongjia Liu; Guangrun Xu; Zhishun Wang
Journal:  Front Aging Neurosci       Date:  2022-08-30       Impact factor: 5.702

7.  Diagnosis of early mild cognitive impairment using a multiobjective optimization algorithm based on T1-MRI data.

Authors:  Jafar Zamani; Ali Sadr; Amir-Homayoun Javadi
Journal:  Sci Rep       Date:  2022-01-19       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.